학술논문

The insulin secretory granule is a hotspot for autoantigen formation in type 1 diabetes
Document Type
Review Paper
Source
Diabetologia: Clinical, Translational and Experimental Diabetes and Metabolism. :1-10
Subject
Autoimmunity
Beta cells
Cathepsin D
Central tolerance
Hybrid insulin peptides
Insulin granules
Neoepitopes
Post-translational modifications
Review
Type 1 diabetes
Language
English
ISSN
0012-186X
1432-0428
Abstract
In type 1 diabetes, the insulin-producing beta cells of the pancreas are destroyed through the activity of autoreactive T cells. In addition to strong and well-documented HLA class II risk haplotypes, type 1 diabetes is associated with noncoding polymorphisms within the insulin gene locus. Furthermore, autoantibody prevalence data and murine studies implicate insulin as a crucial autoantigen for the disease. Studies identify secretory granules, where proinsulin is processed into mature insulin, stored and released in response to glucose stimulation, as a source of antigenic epitopes and neoepitopes. In this review, we integrate established concepts, including the role that susceptible HLA and thymic selection of the T cell repertoire play in setting the stage for autoimmunity, with emerging insights about beta cell and insulin secretory granule biology. In particular, the acidic, peptide-rich environment of secretory granules combined with its array of enzymes generates a distinct proteome that is unique to functional beta cells. These factors converge to generate non-templated peptide sequences that are recognised by autoreactive T cells. Although unanswered questions remain, formation and presentation of these epitopes and the resulting immune responses appear to be key aspects of disease initiation. In addition, these pathways may represent important opportunities for therapeutic intervention.Graphical Abstract: